Sign Up
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

KalVista Pharmaceuticals to present six ePosters on sebetralstat in hereditary angioedema at German Allergy Congress 2025

Written by | 29 Sep 2025 | Allergy

KalVista Pharmaceuticals, Inc. announced the acceptance of six abstracts for ePoster presentation at the 20th German Allergy Congress taking place in Düsseldorf, Germany from October 2–4, 2025.

Details are as follows:

Thursday, October 2 at 4:00–5:15 pm CEST:

  • Time to End of Progression of Hereditary Angioedema Attacks Treated with Sebetralstat: Markus Magerl, Inmaculada Martinez-Saguer, William R. Lumry, John Anderson, Jonathan A. Bernstein, Mauro Cancian, Danny M. Cohn, Henriette Farkas, Henry Li, James Hao, Michael Smith, Paolo Bajcic, Paul Audhya, Petra Staubach, Emel Aygören-Pürsün.
  • Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks in European Participants: Interim Analysis from KONFIDENT-S: Inmaculada Martinez-Saguer, Petra Staubach, Teresa Caballero, Mar Guilarte, Ramon Lleonart Bellfill, James Hao, Michael Smith, Paul Audhya, Markus Magerl, Emel Aygören-Pürsün.
  • Effectiveness of Sebetralstat for the On-demand Treatment of Mucosal Hereditary Angioedema Attacks: Interim Analysis from KONFIDENT-S: Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Jonathan A. Bernstein, Danny M. Cohn, Vesna Grivcheva-Panovska, William R. Lumry, Marc A. Riedl, Andrea Zanichelli, Laurence Bouillet, Ya-Hsiu Chuang, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Henriette Farkas, Petra Staubach, Markus Magerl.
  • Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial: Emel Aygören-Pürsün, Jonathan A. Bernstein, Timothy J. Craig, Paula J. Busse, Teresa Caballero, Danny M. Cohn, Mar Guilarte, Henriette Farkas, Douglas H. Jones, Sorena Kiani-Alikhan, Michael E. Manning, Marcus Maurer, Marc A. Riedl, Sinisa Savic, H. James Wedner, Patrick F. K. Yong, Andrea Zanichelli, Erik Hansen, James Hao, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, William R. Lumry.
  • Sebetralstat For Treatment of HAE Attacks in Patients Receiving Berotralstat: Interim Analysis From the KONFIDENT-S Open-label Study: Markus Magerl, Inmaculada Martinez-Saguer, Michael E. Manning, Marc A. Riedl, Raffi Tachdijan, H. Henry Li, H. James Wedner, Daniel F. Soteres, James Hao, Michael D. Smith, Paul K. Audhya, Tamar Kinaciyan, Petra Staubach, Emel Aygören-Pürsün.

Saturday, October 4 at 10:15–11:15 am CEST:

  • Barriers to Timely Treatment of Hereditary Angioedema Attacks in German Patients: Thomas Buttgereit, Markus Magerl, Sherry Danese, Julie Ulloa, Paolo Bajcic, Paul K. Audhya, Inmaculada Martinez-Saguer.
Newsletter Icon

Register for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.